Carbinoxamine
Links shared publicly online about this topic
ARBINOXA (Carbinoxamine) drug information from MPR
empr.com — “ARBINOXA (Carbinoxamine) drug information for Allergy~systemic antiallergic drugs, Urticaria~antihistamines from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on June 22, 2011 at 4:45 am By:
MPR News: ARBINOXA: Monograph added. http://bit.ly/lu9yEw
ARBINOXA ORAL SOLUTION (Carbinoxamine) drug information from MPR
empr.com — “ARBINOXA ORAL SOLUTION (Carbinoxamine) drug information for Allergy~systemic antiallergic drugs, Urticaria~antihistamines from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on June 22, 2011 at 4:45 am By:
MPR News: ARBINOXA ORAL SOLUTION: Monograph added. http://bit.ly/kq4D0a
NDA Accepted for Extended-Release Carbinoxamine Oral Suspension for Allergies - ONA
oncologynurseadvisor.com — “Tris Pharma announced that the FDA has accepted the New Drug Application of its extended-release carbinoxamine oral suspension for the treatment of allergies in children 2 years.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 9, 2011 at 6:23 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
NDA Accepted for Extended-Release Carbinoxamine Oral Suspension for Allergies http://goo.gl/fb/Rd0md
NDA Accepted for Extended-Release Carbinoxamine Oral Suspension for Allergies - MPR
empr.com — “Tris Pharma announced that the FDA has accepted the New Drug Application of its extended-release carbinoxamine oral suspension for the treatment of allergies in children 2 years.” View full resource at empr.com
Most Recently Shared on March 9, 2011 at 6:53 pm By:
MPR News: NDA Accepted for Extended-Release Carbinoxamine Oral Suspension for Allergies: Tris Pharma announced t... http://bit.ly/icIwyC
Unapproved Drugs: Enforcement Actions
fda.gov — “Unapproved Drugs: Enforcement Actions” View full resource at fda.gov
Most Recently Shared on March 3, 2010 at 6:58 pm By:
RT @FDA_Drug_Info: Follow-up letters sent to manufacturers of unapproved morphine sulfate IR 20 mg/mL products. http://bit.ly/UN_MS
Arbinoxa Tablets and Oral Solution Available for Allergies - MPR
empr.com — “Hawthorn Pharmaceuticals announced that Arbinoxa (carbinoxamine) tablets and oral solution are available for the treatment of allergic (seasonal and perennial) and vasomotor rhinitis, conjunctivitis, urticaria, angioedema, and reactions to blood.” View full resource at empr.com
Most Recently Shared on May 5, 2011 at 6:28 pm By:
MPR News: Arbinoxa Tablets and Oral Solution Available for Allergies: Hawthorn Pharmaceuticals announced that Ar... http://bit.ly/iWMZyD
Arbinoxa Tablets and Oral Solution Available for Allergies - ONA
oncologynurseadvisor.com — “Hawthorn Pharmaceuticals announced that Arbinoxa (carbinoxamine) tablets and oral solution are available for the treatment of allergic (seasonal and perennial) and vasomotor rhinitis, conjunctivitis, urticaria, angioedema, and reactions to blood.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 5, 2011 at 6:11 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Arbinoxa Tablets and Oral Solution Available for Allergies http://goo.gl/fb/XsHln
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
Advertisement
